MECOM and leukemia: Introduction of EVI1 via retroviral expression in hematopoietic stem/progenitor cells (HSPCs) led to the development of MDS in mice, while these mice were unable to develop AML with long latencies (20), suggesting that EVI1 alone is insufficient to induce leukemia in mice.